Abstract Background Long non‐coding RNAs (lncRNAs) could be attractive circulating
biomarkers for cardiovascular risk stratification in subjects at high atherosclerotic …

Elevated lipoprotein (a)[Lp (a)], a predominantly genetic disorder, is a causal risk factor for
atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valvular disease …

Small interfering RNA (siRNA) represents a novel, fascinating therapeutic strategy that
allows for selective reduction in the production of a specific protein through RNA …

Importance Lipoprotein (a)(Lp [a]) is a genetically determined risk-enhancing factor for
atherosclerotic cardiovascular disease (ASCVD). The Lp (a) distribution among the diverse …

BACKGROUND: High levels of Lp (a)(lipoprotein (a)) are associated with multiple forms of
cardiovascular disease. Lp (a) consists of an apoB100-containing particle attached to the …

Abstract Purpose of Review Atherosclerotic cardiovascular disease (ASCVD) is still the
leading cause of death worldwide. Despite excellent pharmacological approaches, clinical …

The presence of a myocardial infarction at a younger age is of special interest, considering
the psychological and socioeconomic impact, as well as long-term morbidity and mortality …

Reducing dietary saturated fatty acids (SFA) intake results in a clinically significant lowering
of low-density lipoprotein cholesterol (LDL-C) across ethnicities. In contrast, dietary SFA's …

Purpose This study reviewed the contribution of inflammation to atherosclerotic
cardiovascular disease (ASCVD), which has gained widespread recognition in recent years …

Aspirin has long been recognized as a beneficial treatment for atherosclerotic
cardiovascular disease (ASCVD) due to its antiplatelet effects. However, there is a need to …